tiprankstipranks
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Income Statement

Compare
253 Followers

Lantern Pharma Income Statement

Last quarter (Q3 2024), Lantern Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lantern Pharma's net income was $-4.51M. See Lantern Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -174.84K$ -154.68K$ -97.42K$ -3.39K$ -1.63K
Operating Expenses
$ 17.88M$ 14.43M$ 12.59M$ 5.91M$ 2.43M
Depreciation and Amortization
$ 174.84K$ 154.68K$ 97.42K$ 3.39K$ 1.63K
EBITDA
$ -15.79M$ -14.42M$ -12.27M$ -5.90M$ -2.43M
Operating Income
$ -17.88M$ -14.43M$ -12.59M$ -5.91M$ -2.43M
Other Income/Expenses
$ 1.92M$ 172.81K$ 228.48K$ 0.00$ 0.00
Pretax Income
$ -15.96M$ -14.26M$ -12.36M$ -5.91M$ -2.43M
Net Income
$ -15.96M$ -14.09M$ -12.30M$ -5.91M$ -2.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.47$ -1.30$ -1.13$ -0.95$ -0.39
Diluted EPS
$ -1.47$ -1.30$ -1.13$ -0.95$ -0.39
Weighted Average Shares Outstanding
10.84M 10.85M 10.90M 6.22M 6.27M
Weighted Average Shares Outstanding (Diluted)
10.84M 10.85M 10.90M 6.22M 6.27M
Currency in USD

Lantern Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis